Brain, Vol. 125, No. 8, 1751-1759,
August 2002
© 2002 Guarantors of Brain
The natural history of Rasmussen’s encephalitis
Departments of 1 Epileptology, 2 Radiology/Neuroradiology, 3 Neuropathology and 4 Neurosurgery, University of Bonn, Bonn, Germany
Correspondence to: C. G. Bien, Department of Epileptology, University of Bonn, Sigmund-Freud-Strasse 25, D-53105 Bonn, Germany E-mail: christian.bien{at}ukb.uni-bonn.de
Rasmussen’s encephalitis (RE) is a chronic inflammatory disease of unknown origin, usually affecting one brain hemisphere. In the present study, a comprehensive assessment of the natural history of the disorder is presented. Seizure frequency, degree of hemiparesis and degree of cerebral hemiatrophy in 13 patients with histopathologically proven RE are analysed over the time course prior to resective epilepsy surgery or introduction of long-term immunosuppressive pharmacotherapy. For the assessment of the degree of cerebral hemiatrophy, on defined slices comprising the Sylvian fissure of hard copies of serial MRI investigations, the hemispheric ratio (HR) was determined. The data show an initial prodromal phase with an intermediate frequency of focal onset seizures and mostly no hemiparesis. The occurrence of this stage was mainly observed in the adolescent and adult patients. All patients went through an acute phase with a median duration of 8 months. During this stage, there were frequent simple partial motor seizures, development of hemiparesis and volume loss of the affected hemisphere. After this, the patients passed into a residual stage with a marked decrease in seizure frequency. Twelve months after the onset of the acute stage, the average HR was 0.72. These data allow an estimation of the prognosis of newly affected patients, and demonstrate that most of the brain damage in RE occurs during the first 8–12 months. These findings should be taken into consideration when future therapeutic approaches to RE are evaluated.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  M. Matsuo, Y. Takahashi, K. Taniguchi, K. Sasaki, and Y. Hamasaki Chronic Myoclonia of Subcortical Origin With Antiglutamate Receptor Antibodies J Child Neurol, December 1, 2007; 22(12): 1393 - 1396. [Abstract] [PDF]
|
|
|
|
 |
|
 C M Quesada, H Urbach, C E Elger, and C G Bien Rasmussen encephalitis with ipsilateral brain stem involvement in an adult patient J. Neurol. Neurosurg. Psychiatry, February 1, 2007; 78(2): 200 - 201. [Full Text] [PDF]
|
|
|
|
|
|
B. Tziperman, B.-Z. Garty, N. Schoenfeld, V. Hoffer, N. Watemberg, D. Lev, Y. Ganor, M. Levite, and T. Lerman-Sagie Acute Intermittent Porphyria, Rasmussen Encephalitis, or Both? J Child Neurol, January 1, 2007; 22(1): 99 - 105. [Abstract] [PDF]
|
|
|
|
 |
|
 J. Gawler A "glioma" that was cured Practical Neurology, April 1, 2006; 6(2): 117 - 121. [Full Text] [PDF]
|
|
|
|
 |
|
 R. Watson, J.E.C. Jepson, I. Bermudez, S. Alexander, Y. Hart, K. McKnight, A. Roubertie, F. Fecto, J. Valmier, D. B. Sattelle, et al. {alpha}7-Acetylcholine receptor antibodies in two patients with Rasmussen encephalitis Neurology, December 13, 2005; 65(11): 1802 - 1804. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Larionov, R. Konig, H. Urbach, R. Sassen, C. E. Elger, and C. G. Bien MRI brain volumetry in Rasmussen encephalitis: The fate of affected and "unaffected" hemispheres Neurology, March 8, 2005; 64(5): 885 - 887. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. G. Bien, T. Granata, C. Antozzi, J. H. Cross, O. Dulac, M. Kurthen, H. Lassmann, R. Mantegazza, J.-G. Villemure, R. Spreafico, et al. Pathogenesis, diagnosis and treatment of Rasmussen encephalitis: A European consensus statement Brain, March 1, 2005; 128(3): 454 - 471. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Watson, Y. Jiang, I. Bermudez, L. Houlihan, L. Clover, K. McKnight, J. H. Cross, I. K. Hart, A. Roubertie, J. Valmier, et al. Absence of antibodies to glutamate receptor type 3 (GluR3) in Rasmussen encephalitis Neurology, July 13, 2004; 63(1): 43 - 50. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. G. Bien, U. Gleissner, R. Sassen, G. Widman, H. Urbach, and C. E. Elger An open study of tacrolimus therapy in Rasmussen encephalitis Neurology, June 8, 2004; 62(11): 2106 - 2109. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Urbach, J. Hattingen, J. von Oertzen, C. Luyken, H. Clusmann, T. Kral, M. Kurthen, J. Schramm, I. Blumcke, and H. H. Schild MR Imaging in the Presurgical Workup of Patients with Drug-Resistant Epilepsy AJNR Am. J. Neuroradiol., June 1, 2004; 25(6): 919 - 926. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Korn-Lubetzki, C. G. Bien, J. Bauer, M. Gomori, H. Wiendl, L. Trajo, H. Ovadia, B. Wilken, V. H. Hans, C. E. Elger, et al. Rasmussen encephalitis with active inflammation and delayed seizures onset Neurology, March 23, 2004; 62(6): 984 - 986. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Granata, L. Fusco, G. Gobbi, E. Freri, F. Ragona, G. Broggi, R. Mantegazza, L. Giordano, F. Villani, G. Capovilla, et al. Experience with immunomodulatory treatments in Rasmussen's encephalitis Neurology, December 23, 2003; 61(12): 1807 - 1810. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Takahashi, H. Mori, M. Mishina, M. Watanabe, T. Fujiwara, J. Shimomura, H. Aiba, T. Miyajima, Y. Saito, A. Nezu, et al. Autoantibodies to NMDA receptor in patients with chronic forms of epilepsia partialis continua Neurology, October 14, 2003; 61(7): 891 - 896. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Rasmussen's Encephalitis: Natural History Described Journal Watch Neurology, October 11, 2002; 2002(1011): 4 - 4. [Full Text]
|
|